mir|detect Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 5

mir|detect General Information

Description

Developer of a diagnostic testing technology designed to detect testicular cancer. The company's technology helps to develop, produce, and sell sensitive and reliable molecular biological tests for the early detection and diagnosis of cancer, enabling doctors to detect the disease through a radiation-free and safe application.

Contact Information

Formerly Known As
miRdetect UG (haftungsbeschränkt)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fischkai 1
  • 27572 Bremerhaven
  • Germany
+49 0421
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Fischkai 1
  • 27572 Bremerhaven
  • Germany
+49 0421

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

mir|detect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 02-Jan-2023 Completed Generating Revenue
4. Early Stage VC 29-Nov-2019 Completed Clinical Trials - General
3. Seed Round 23-Jan-2019 Completed Clinical Trials - General
2. Grant Completed Startup
1. Grant 01-Jan-2017 $2.1K Completed Startup
To view mir|detect’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

mir|detect Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic testing technology designed to detect testicular cancer. The company's technology helps to dev
Diagnostic Equipment
Bremerhaven, Germany
9 As of 2025

Mechelen, Belgium
 

Nehren, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

mir|detect Competitors (28)

One of mir|detect’s 28 competitors is Biocartis, a Venture Capital-Backed company based in Mechelen, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocartis Venture Capital-Backed Mechelen, Belgium
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
T2 Biosystems Formerly VC-backed Lexington, MA
Abionic Venture Capital-Backed Lausanne, Switzerland
DNAe Formerly VC-backed London, United Kingdom
You’re viewing 5 of 28 competitors. Get the full list »

mir|detect Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

mir|detect Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Regional Development Fund (Brandenburg) Government Minority
MediVentures Venture Capital Minority
Bremer Aufbau-Bank Impact Investing Minority
High-Tech Gründerfonds Venture Capital Minority
Science4Life Accelerator/Incubator
To view mir|detect’s complete investors history, request access »

mir|detect FAQs

  • When was mir|detect founded?

    mir|detect was founded in 2014.

  • Where is mir|detect headquartered?

    mir|detect is headquartered in Bremerhaven, Germany.

  • What is the size of mir|detect?

    mir|detect has 9 total employees.

  • What industry is mir|detect in?

    mir|detect’s primary industry is Diagnostic Equipment.

  • Is mir|detect a private or public company?

    mir|detect is a Private company.

  • What is mir|detect’s current revenue?

    The current revenue for mir|detect is .

  • How much funding has mir|detect raised over time?

    mir|detect has raised $2.21M.

  • Who are mir|detect’s investors?

    European Regional Development Fund (Brandenburg), MediVentures, Bremer Aufbau-Bank, High-Tech Gründerfonds, and Science4Life have invested in mir|detect.

  • Who are mir|detect’s competitors?

    Biocartis, Hain Lifescience, T2 Biosystems, Abionic, and DNAe are some of the 28 competitors of mir|detect.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process